• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15923 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2014 NIHR Health Technology Assessment programme Imatinib for the adjuvant treatment of gastrointestinal stromal tumours
2014 Agency for Healthcare Research and Quality (AHRQ) Primary care screening for abdominal aortic aneurysm: a systematic evidence review for the U.S. preventive services task force
2014 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Atomoxetine (Strattera®)
2014 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Abatacept (Orencia®)
2014 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Linaclotide (Constella®)
2014 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Nalmefene (Selincro®)
2014 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Nab-Paclitaxel (Abraxane®, Ebetaxel®) as first-line therapy for metastatic adenocarcinoma of the pancreas
2014 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Alpharadin, radium-223 Chloride (Xofigo®) for the treatment of patients with symptomatic hormone refractory prostate cancer with skeletal metastases
2014 The Swedish Council on Health Technology Assessment (SBU) [Aromatase inhibitors for early-stage breast cancer]
2014 HAYES, Inc. Computerized Neurocognitive Testing (CNT) for sports-related head injury
2014 HAYES, Inc. High-frequency chest wall compression for diseases other than cystic fibrosis
2014 HAYES, Inc. Intrathecal opioids for chronic noncancer pain
2014 HAYES, Inc. Intravenous immunoglobulin for rheumatic diseases
2014 HAYES, Inc. Intravenous vitamin C for the treatment of cancer
2014 HAYES, Inc. Percutaneous mitral valve repair
2014 HAYES, Inc. Positron Emission Tomography (PET) for metastatic melanoma
2014 HAYES, Inc. Robotically assisted hysterectomy
2014 HAYES, Inc. Sensory integration therapy for non-autistic children
2014 HAYES, Inc. Smoking cessation in patients with schizophrenia
2014 HAYES, Inc. The use of Information Communication Technology (ICT) to improve treatment adherence in patients with diabetes
2014 HAYES, Inc. Transcranial direct current stimulation for depression
2014 HAYES, Inc. Transcranial magnetic stimulation for treatment-resistant depression
2014 HAYES, Inc. Transcranial Magnetic Stimulation (TMS) to enhance pharmacotherapy for depression
2014 HAYES, Inc. Afirma thyroid FNA analysis
2014 HAYES, Inc. ERCC1 expression analysis in Non-Small Cell Lung Cancer (NSCLC)
2014 HAYES, Inc. HERmark breast cancer assay
2014 HAYES, Inc. Immunoglobulin gene testing for B-cell leukemia
2014 HAYES, Inc. L1 syndrome (L1CAM-related disorders)
2014 HAYES, Inc. PTEN gene expression testing in Non-Small Cell Lung Cancer (NSCLC)
2014 HAYES, Inc. Von Hippel-Lindau (VHL) syndrome
2014 HAYES, Inc. Apnea Risk Evaluation System (ARES; Watermark Medical Inc.) for diagnosis of obstructive sleep apnea
2014 HAYES, Inc. ATI neurostimulation system (Autonomic Technologies Inc.) for electrical stimulation of the Sphenopalatine Ganglion (SPG) for headache
2014 HAYES, Inc. Catalys precision laser system (OptiMedica Corp.; Abbott Medical Optics) for cataract surgery
2014 HAYES, Inc. iFuse implant system (SI-BONE Inc.) for sacroiliac joint fusion for treatment of low back pain
2014 HAYES, Inc. Inhaled nitric oxide for Acute Respiratory Distress Syndrome (ARDS) in adults
2014 HAYES, Inc. Laser hair removal for prevention of pilonidal sinus recurrence
2014 HAYES, Inc. Magnetic Resonance-guided Focused Ultrasound (MRgFUS) therapy (ExAblate; InSightec Ltd.) for ablation of uterine fibroids
2014 HAYES, Inc. Negative pressure wound therapy after fasciotomy
2014 HAYES, Inc. Nonpulsed (Thermal) percutaneous Radiofrequency Ablation (RFA) for treatment of cervicogenic headache
2014 HAYES, Inc. Open surgery for sacroiliac joint fusion for the treatment of low back pain
2014 HAYES, Inc. Portable pneumatic compression versus low-molecular-weight heparin for prevention of deep vein thrombosis after lower-extremity joint arthroplasty
2014 HAYES, Inc. Portable versus non-portable intermittent pneumatic compression for prevention of postoperative deep vein thrombosis
2014 HAYES, Inc. Pronto-7 with rainbow 4D technology (Masimo Corp.) for noninvasive hemoglobin measurement
2014 HAYES, Inc. Split-night polysomnography for Continuous Positive Airway Pressure (CPAP) titration in adults with obstructive sleep apnea
2014 HAYES, Inc. X stop interspinous process decompression system (Medtronic Spine LLC) for lumbar spinal stenosis
2014 NIHR Health Technology Assessment programme Dabrafenib for treating unresectable, advanced or metastatic BRAFV600 mutation-positive melanoma (ID605)
2014 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tenofovir disoproxil fumarate (Viread®)
2014 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Indacaterol/glycopyrronium (Ultibro® Breezhaler®)
2014 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Darunavir (Prezista®)
2014 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tocilizumab (RoActemra®)
2014 NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial
2014 NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of brief intervention for excessive alcohol consumption among people attending sexual health clinics: a randomised controlled trial (SHEAR)
2014 NIHR Health Technology Assessment programme Rehabilitation aimed at improving outdoor mobility for people after stroke: a multi-centre randomised controlled study (the Getting out of the House Study)
2014 Agency for Healthcare Research and Quality (AHRQ) Smoking cessation interventions in pregnancy and postpartum care
2014 Agency for Healthcare Research and Quality (AHRQ) Low-dose aspirin for the prevention of morbidity and mortality from pre-eclampsia: a systematic evidence review for the U.S. preventive services task force
2014 Agency for Healthcare Research and Quality (AHRQ) Primary care behavioral interventions to prevent or reduce illicit drug and nonmedical pharmaceutical use in children and adolescents: a systematic evidence review for the U.S. preventive services task force
2014 Agency for Healthcare Research and Quality (AHRQ) Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: systematic review to update the U.S. preventive services task force recommendation
2014 Agency for Healthcare Research and Quality (AHRQ) Antiplatelet and anticoagulant treatments for unstable angina/non–ST elevation myocardial infarction
2014 Agency for Healthcare Research and Quality (AHRQ) Meditation programs for psychological stress and well-being
2014 Agency for Healthcare Research and Quality (AHRQ) Benefits and harms of routine preoperative testing: comparative effectiveness
2014 Agency for Healthcare Research and Quality (AHRQ) Combination therapy versus intensification of statin monotherapy: an update
2014 Agency for Healthcare Research and Quality (AHRQ) Pharmacologic therapies for the management of crohn's disease: comparative effectiveness
2014 Agency for Healthcare Research and Quality (AHRQ) Oral mechanical bowel preparation for colorectal surgery
2014 Agency for Healthcare Research and Quality (AHRQ) Pharmacotherapy for adults with alcohol-use disorders in outpatient settings
2014 Agency for Healthcare Research and Quality (AHRQ) Transitional care interventions to prevent readmissions for people with heart failure
2014 NIHR Health Technology Assessment programme A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures
2014 NIHR Horizon Scanning Centre (NIHR HSC) Pertuzumab (Perjeta) for HER2-positive locally advanced, inflammatory or early breast cancer – neo-adjuvant in combination with trastuzumab and docetaxel
2014 NIHR Horizon Scanning Centre (NIHR HSC) Pacritinib for myelofibrosis
2014 NIHR Horizon Scanning Centre (NIHR HSC) Paclitaxel poliglumex (Xyotax) for advanced ovarian cancer – maintenance therapy
2014 NIHR Horizon Scanning Centre (NIHR HSC) Necitumumab in combination with gemcitabine and cisplatin for advanced and metastatic non-small cell lung cancer – first line
2014 NIHR Horizon Scanning Centre (NIHR HSC) Midostaurin for newly diagnosed FLT3-mutated acute myeloid leukaemia – first line
2014 NIHR Horizon Scanning Centre (NIHR HSC) Custirsen for locally advanced or metastatic hormone-relapsed prostate cancer – first and second line
2014 NIHR Horizon Scanning Centre (NIHR HSC) Lumacaftor and ivacaftor combination therapy for cystic fibrosis – first line
2014 NIHR Horizon Scanning Centre (NIHR HSC) Velcalcetide for secondary hyperparathyroidism – first line
2014 NIHR Horizon Scanning Centre (NIHR HSC) Autologous Muscle Derived Cells-Urethral Sphincter Repair (AMDC-USR) for stress urinary incontinence
2014 NIHR Horizon Scanning Centre (NIHR HSC) Purified botulinum toxin type A (Botox) for post-stroke lower limb spasticity
2014 NIHR Horizon Scanning Centre (NIHR HSC) Tocilizumab (RoACTEMRA) for giant cell arteritis – first and second line
2014 NIHR Horizon Scanning Centre (NIHR HSC) Ramucirumab in combination with paclitaxel for advanced gastric cancer and gastro-oesophageal junction adenocarcinoma after prior chemotherapy
2014 NIHR Horizon Scanning Centre (NIHR HSC) Onartuzumab for metastatic Met positive gastric or gastro-oesophageal junction cancer
2014 NIHR Horizon Scanning Centre (NIHR HSC) Obinutuzumab in combination with CHOP chemotherapy for CD20-positive diffuse large B-cell lymphoma – first line
2014 NIHR Horizon Scanning Centre (NIHR HSC) Obinutuzumab in combination with bendamustine for rituximab-refractory indolent non-Hodgkin's lymphoma – second line
2014 NIHR Horizon Scanning Centre (NIHR HSC) Ixazomib citrate for relapsed and/or refractory multiple myeloma
2014 NIHR Horizon Scanning Centre (NIHR HSC) HA-irinotectan for metastatic colorectal cancer – second and third line
2014 NIHR Horizon Scanning Centre (NIHR HSC) Inotuzumab ozogamicin for acute lymphoblastic leukaemia – second or subsequent line
2014 NIHR Horizon Scanning Centre (NIHR HSC) Idelalisib and ofatumumab for relapsed chronic lymphocytic leukaemia
2014 NIHR Horizon Scanning Centre (NIHR HSC) Etirinotecan pegol for metastatic breast cancer - second or subsequent line
2014 NIHR Horizon Scanning Centre (NIHR HSC) Cediranib for ovarian cancer – second line
2014 NIHR Horizon Scanning Centre (NIHR HSC) Alisertib for relapsed or refractory peripheral T-cell lymphoma – second and subsequent line
2014 NIHR Horizon Scanning Centre (NIHR HSC) Cholic acid (Orphacol) for inborn errors of primary bile acid synthesis – first line
2014 NIHR Horizon Scanning Centre (NIHR HSC) Migalastat for Fabry disease: update
2014 NIHR Horizon Scanning Centre (NIHR HSC) Denosumab for glucocorticoid-induced osteoporosis
2014 NIHR Horizon Scanning Centre (NIHR HSC) Perampanel for adjuvant treatment of primary generalised tonic-clonic seizures
2014 NIHR Horizon Scanning Centre (NIHR HSC) Daclatasvir and sofosbuvir (Sovaldi) with and without ribavirin for chronic hepatitis C infection
2014 NIHR Horizon Scanning Centre (NIHR HSC) Tofacitinib for moderate to severe active ulcerative colitis
2014 NIHR Horizon Scanning Centre (NIHR HSC) Ixazomib in combination with oral dexamethasone for relapsed or refractory systemic light chain (AL) amyloidosis
2014 NIHR Horizon Scanning Centre (NIHR HSC) Levosimendan (Leximda) for severe acute decompensated chronic heart failure – second line
2014 NIHR Horizon Scanning Centre (NIHR HSC) BreathLink™ for breast cancer screening
2014 NIHR Horizon Scanning Centre (NIHR HSC) The ViewRay™ System for MRI-guided radiotherapy
2014 NIHR Horizon Scanning Centre (NIHR HSC) Sheffield Support Snood for neurodegenerative conditions
2014 NIHR Horizon Scanning Centre (NIHR HSC) Reducer stent for refractory angina